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ABSTRACT: Alteration of mitochondrial functions such as permeability transition (PT), a process associated with 
the uncoupling of oxidative phosphorylation, has been found to play a vital role in the apoptotic process induced by 
certain anti-cancer agents. When triggered, PT facilitates the release of mitochondrial apoptogenic proteins which 
in turn activate the caspase cascade of apoptosis. Thus, this study investigated the in vitro effects of varying 
concentrations (0.2, 0.4, 0.6, 0.8 and 1.0 mg/ml) of different leaf extracts [Crude Water-Soluble Extract (CWSE), 
Decoction (DE) and Methanol Extract (ME)] of Momordica charantia (M. charantia), a purported anti-cancer plant of 
the family Cucurbitaceae on normal rat liver mitochondria. Opening of mitochondrial membrane permeability 
transition pore (MMPTP) was spectrophotometrically assayed under succinate-energized condition. Results 
obtained showed concentration-dependent and significant (P<0.05) increases in the extents to which MMPTP 
opening was induced by the three extract types when compared with the control group. Inductions caused by CWSE 
and DE increased with increasing concentrations while those caused by ME decreased with increasing 
concentrations, giving the maximum induction at 1.0 mg/ml (8.1-fold increase) of CWSE and the least induction at 
1.0 mg/ml (4.3-fold increase) of ME, respectively. Spermine, a reference inhibitor of MMPTP opening, reversed all 
observed openings. These results indicate that the tested leaf extracts of M. charantia are potent (CWSE being the 
most potent) MMPTP opening inducers and the pathway by which M. charantia causes apoptosis in cancer cells is 
probably mitochondrial-mediated (intrinsic). 
KEYWORDS: Mitochondrial membrane permeability transition pore (MMPTP), Momordica charantia, Apoptosis, 
Spermine. 
BKM.2013.009 © 2013 Nigerian Society for Experimental Biology; All rights reserved. Printed in Nigeria 
This article is downloadable online in PDF format at http://www.bioline.org.br/bk 
 
INTRODUCTION 
Mitochondria are fascinating organelles that fulfill multiple 
functions as diverse as energy production, fatty acid ß-
oxidation, reactive oxygen species (ROS) production and 
detoxification, and cell death regulation. The co-ordination of 
these functions relies on autonomous mitochondrial 
processes as well as sustained cross-talk with other 
organelles and/or the cytosol. Thus, a tight regulation of 
mitochondrial functions ensures cell homeostasis (Martel et 
al., 2012). Permeability transition (PT), a phenomenon 
caused by the opening of a voltage-dependent, high-
conductance channel (known as the permeability transition 
pore located in the inner mitochondrial membrane), is a 
sudden increase of inner mitochondrial permeability to 
solutes with molecular mass up to 1.5 kDa. PT is implicated 
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in apoptosis or necrosis as an important event in the control 
of cell death or survival (Zoratti and Szabo, 1995; Ling et al., 
2010). Opening of the mitochondrial membrane permeability 
transition pore (MMPTP) causes the cell to show the 
characteristics of apoptosis by promoting the release of 
apoptotic proteins (Ling et al., 2010). Apoptosis is a 
regulated form of cellular suicide that is tightly controlled by a 
genetic program (Yaun and Horvtiz, 2004) and it can be 
induced by a variety of stimuli, including ligation of cell 
surface receptors, serum deprivation and chemotherapeutic 
agents, among others (Wyllie et al., 1984). Apoptosis 
dysregulation contributes to half of all human diseases. 
Excessive apoptosis occurs in neurodegenerative disorders 
such as Alzheimers, Parkinsons, autoimmune disorders, 
heart disease and infectious diseases, including AIDS (Singh 
and Anand, 1994) while failure to initiate apoptosis can 
induce many diseased states, the most well documented 
being arthritis and cancer; in which the normal constraints on 
the life span of a differentiated cell are not present, so the 
cell is not eliminated (Kerr et al., 1972). With the foregoing, 
apoptosis has been tipped as one of the potent defenses 
against cancers, since the process eliminates potentially 
deleterious, mutated cells (Reed, 1999). Apoptosis occurs 
primarily via two well-recognized pathways in cells (Lockshin 
and Zakeri, 2004; Danial and Korsmeyer, 2004); the 
extrinsic, or death receptor-mediated and the intrinsic, or 
mitochondrial-mediated, pathways (Reed, 2004). The 
intrinsic apoptotic pathway relies primarily on the 
permeabilization of mitochondrial membranes, with 
associated release of apoptogenic mitochondrial proteins, 
leading to activation of caspase-9 and downstream cleavage 
of caspases 3, 6, or 7 (Guimaraes and Linden, 2004) and is 
characterized by alteration in mitochondrial polarization and 
release of such mitochondrial proteins as cytochrome c, 
which in turn can trigger caspase activation and ultimately 
execution of apoptosis (Sun et al., 2004). M. charantia, Linn. 
(Family: Cucurbitaceae), commonly called bitter melon, is an 
economically important medicinal plant (Paul and 
Raychaudhuri, 2010) commonly cultivated in tropical regions 
of India, China, East Africa and Central and South America. 
It is herbaceous, climbing or having prostate vines with 
simple or forked tendrils (Garau et al., 2003). The parts of 
the plant used medicinally include the fruit, leaves, seeds, 
whole plant and seed oil (Anon, 1999). The whole plant is a 
known anti-diabetic agent, and is used also for expelling 
intestinal gas, for treating tumors, wounds, rheumatism, 
malaria and vaginal discharge, and as an abortifacient 
(Taylor, 2005; Sofowora, 2006). The fruits and seeds of bitter 
melon have been reported to possess medicinal properties 
such as anti−HIV, anti−cancer, anti−inflammatory, 
anti−leukemic, anti−microbial, anti−tumor and anti−diabetic 
(Taylor, 2002). The popularity of M. charantia in traditional 
medicine suggests that it contains bioactive agents that will 
be potentially useful in drug development and such 
phytochemicals as alkaloids, tannins, flavonoids, saponins 
and glycosides have been found in its leaf extracts (Bakare 
et al., 2010). Quite a number of reports (Singh et al., 1989; 
Srivastava et al., 1993; Ng et al., 1994; Platel and 
Srinivasan, 1997; Naseem et al., 1998), have shown the 
efficacy of various parts of the plant (seed, fruit and even the 
whole plant) extracted in different media, such as benzene, 
alcohol, petroleum ether, acetone, water and as crude 
extracts and juices in the treatment of many ailments. Most 
importantly, some of these studies have shown its efficacy in 
various cancers including breast cancer, skin tumor, prostatic 
cancer and human bladder carcinomas (Grover and Yadav 
2004). In fact, the efficacy of M. charantia against some of 
the aforementioned cancers has been linked to its ability to 
induce apoptosis (Kobori et al., 2008; Fang et al., 2012) in 
tandem, with the observation that many dietary bioactive 
agents have been found to induce apoptosis through the 
intrinsic mitochondrial-mediated pathway (Chen and King, 
2005). However, there is paucity of information on the role 
played by M. charantia in the induction of apoptosis via the 
intrinsic pathway and, by extension, induction of the MMPTP 
opening. Thus, this study seeks to ascertain if M. charantia is 
a potent inducer of the MMPTP opening, a vital prerequisite 
for the intrinsic apoptotic pathway.  
 
MATERIALS AND METHODS 
Plant  
The leaves of M. charantia were purchased from the Elewe 
Omo section of the Oje market in Ibadan, Oyo State, Nigeria 
and authenticated by Prof. Abiodun Ayodele, a Plant 
Taxonomist of the Department of Botany, University of 
Ibadan, Nigeria. The voucher number is UIH-22369. Repeat 
purchases of M. charantia leaves were from the same 
source, and the plant taxonomist authenticated each sample 
collected. 
Extraction of the crude water-soluble extract (CWSE) of 
M. charantia Leaves 
Fresh leaves of M. charantia were washed with distilled 
water to remove dust and then cut into small pieces. 200 g of 
leaves was liquidized in 100 ml distilled water for 5−10 min 
using a blender. The resulting homogenate was centrifuged 
at 4000 rpm for 30 min and the suspension was filtered by 
passage through a glass funnel containing sterile cotton 
wool. The filtrate obtained was lyophilized and stored at 4 °C 
until further use. The yield was about 1.9% with reference to 
the fresh leaves. 
Extraction of the decoction (DE) of M. charantia leaves 
Fresh leaves of M. charantia were made into a decoction 
based on a modification of the method of Cunnick and 
Takemoto (1993). In brief, fresh leaves were thoroughly 
washed with distilled water, drained and chopped. 200 g of 
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the chopped leaves were then boiled in 400 ml of distilled 
water until the volume became half of the original volume 
(200 ml). The decoction was then filtered by passage 
through a separating funnel containing sterile cotton wool. 
The filtrate obtained was lyophilized and stored at 4 °C until 
further use. The yield was about 1.7% of the raw material.   
Preparation of the Methanol extract (ME) of M. charantia 
leaves 
Leaf extracts were prepared by the method of Alade and 
Irobi (1993) with minor modifications. Briefly, 200 g of shade-
dried leaves of M. charantia was ground into powder and 
soaked in 2 litres 95% methanol for 72 hours with intermittent 
shaking. At the end of the extraction, the extract was filtered 
using a separating funnel containing sterile cotton wool and 
concentrated in vacuo at 40°C. The dried residue of the 
crude extract was stored at 4°C until further use. The yield 
was about 7.5% of the raw material. In all cases, a portion of 
the dried extract was weighed and dissolved in distilled water 
to make appropriate concentrations for the study. 
Experimental animals  
Twenty five Wistar strain albino male rats (4 months old; 
approximately 220 g) were obtained and kept at the Faculty 
of Basic Medical Sciencesʼ Animal House, LAUTECH, 
Ogbomoso, Nigeria, under light-controlled conditions 
(12h−light/12h−dark cycle) and in well-ventilated plastic 
cages. The animals received feeds (Ladokun Pelleted feeds) 
and water ad libitum, were allowed to acclimatize over a 
period of two weeks and cared for in accordance with good 
laboratory animal care practice prescribed by the Faculty of 
Basic Medical Sciencesʼ Animal Care and Use Committee. 
Chemicals and reagents  
Sodium Carbonate (Na2CO3), Sodium Hydroxide (NaOH), 
Sodium-Potassium Tartarate (Na-K-C4O6), Hydrated Copper 
Sulphate (CuSO4.5H2O), Calcium Chloride (CaCl2), 
Potassium Hydroxide (KOH), Ethanol and Methanol were 
Products of BDH Poole, UK Ltd. and Co., while Folin 
Ciocalteau Reagent, BSA, Mannitol, Sucrose, HEPES [4-(2-
Hydroxyethyl) piperazine-1-ethanesulfonic acid], EGTA, 
Spermine, Rotenone, and Sodium Succinate hexahydrate 
were Products of Sigma-Aldrich Co, USA.  All Chemicals 
were of analytical grade.  
Mitochondrial isolation 
After overnight fasting, the animals were sacrificed by 
cervical dislocation and livers were isolated essentially 
according to the method of Olorunsogo et al., (1984) and as 
reported by Lapidus and Sokolove (1993). Livers were 
rapidly excised, trimmed to remove excess tissues and 
washed in a buffer containing 210 mM Mannitol, 70 mM 
Sucrose, 5 mM HEPES, 1 M KOH, and 1 mM EGTA, pH 7.4. 
Thereafter the livers were weighed, chopped and suspended 
in the same buffer to make a 10% homogenate. The 
suspension was immediately homogenized on ice using a 
Porter glass homogenizer. The homogenate was centrifuged 
in an SM-18B High Speed Refrigerated Centrifuge twice at 
2500 rpm for 5 min to remove the nuclear fraction and 
cellular debris. Supernatants obtained were centrifuged at 
13000 rpm for 10 min and the mitochondrial fractions 
obtained were washed three times at 12000 rpm for 10 min 
with a washing buffer which contained 210 mM Mannitol, 
70mM Sucrose, 5mM HEPES-KOH and 0.5% BSA, pH 7.4. 
The mitochondrial pellets were suspended in swelling buffer 
(210 mM Mannitol, 70 mM Sucrose, and 5 mM HEPES-KOH, 
pH 7.4) and immediately dispensed in 1 ml Eppendorf tubes. 
Isolated mitochondria were used within 3 hours of isolation.  
	  
Figure 1: In vitro Ca2+ - induced opening of rat liver MMPTP and 
inhibition of the opening by spermine. A: No Triggering (Control); 
B: Triggering Agent (300 µM CaCl2); C: Spermine inhibition (300 µM 
CaCl2 + 4 mM Spermine). Rat liver mitochondria (0.4 mg/ml 
(protein/ml)) were incubated in a l-cm cuvette in the presence of 80 
µM rotenone in swelling buffer (210 mM Mannitol, 70 mM Sucrose, 5 
mM HEPES-KOH pH 7.4) for about 3 min at 30 °C prior to the 
addition of 300 µM CaCl2 (triggering agent). Thirty seconds later, 50 
µM of 5 mM sodium succinate was added and mitochondrial 
permeability was quantified as changes in absorbance at 540 nm. 
Spermine (4 mM) was added immediately after the addition of 
rotenone and just before the addition of mitochondria for the 
determination of spermine inhibition while the addition of 300 µM 
CaCl2 was omitted in assays without triggering agent. Trace A 
shows a population of intact mitochondria respiring on succinate (not 
appreciable mitochondrial swelling as shown by little or no change in 
absorption of light at 540 nm), Trace B shows mitochondrial swelling 
caused by 300 µM CaCl2 and Trace C shows spermine inhibition of 
calcium-induced mitochondrial swelling (The Ca2+−induced changes 
in absorption of light measured at 540 nm were reversed). The 
results shown are representative of five such experiments. 
Assessment of mitochondrial membrane 
permeability transition  
Permeability transition is detected in isolated mitochondria by 
the change in the diffraction/absorption of light (measured at 
540 nm) that results from matrix swelling (Zoratti and Szabo, 
1995). Thus, changes in the volume of isolated liver 
mitochondria were measured quantitatively at 540 nm in an 
SM32A spectrophotometer based on the procedure of 
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Lapidus and Sokolove (1993). Mitochondria (0.4 mg of 
protein/ml) were pre-incubated in a 1 cm light path glass 
cuvette in the presence of 80 µM rotenone in swelling buffer 
containing 210 mM Mannitol, 70 mM Sucrose, 5 mM HEPES-
KOH, pH 7.4 for about 3 min at 30°C prior to the addition of 
300 µM CaCl2 (triggering agent). Thirty seconds later, 50 µM 
of 5 mM sodium succinate was added and mitochondrial 
permeability was quantified as changes in absorbance at 540 
nm. 4 mM spermine was added immediately after the 
addition of rotenone and just before the addition of 
mitochondria for the determination of spermine inhibition 
while the addition of 300 µM CaCl2 was omitted in assays 
without triggering agent. For determination of the extents of 
opening of mitochondrial membrane permeability transition 
pore induced by the leaf extracts of M. charantia (CWSE, DE 
and ME), varying concentrations (0.2, 0.4, 0.6, 0.8 and 1.0 
mg/ml) of each extract were immediately introduced after the 
addition of rotenone and just before the addition of 
mitochondria. Absorbance readings were monitored 
continuously for 12 minutes (Lapidus and Sokolove, 1993). 
The 12-minute cut-off was found to be optimal in obtaining a 
wide range of activities of the triggering agent and extracts 
on MMPTP opening. The curves tend to level off between 8 
and 12 min (e.g., Figure 1). Readings up to the 12th minute 
gave sufficient absorbance reading without loss of integrity of 
the mitochondrial samples. Protein concentration was 
estimated according to the method of Lowry et al., (1951) 
using bovine serum albumin (BSA) as the standard.  
Statistical Analysis  
The experiments were repeated 5 times. Since mitochondrial 
assays allow for multiple testing on a particular isolate, each 
mitochondrial isolate was used for testing the effect of as 
many as nine parameters all at a particular concentration 
(e.g., 0.2 mg/ml) for each experimental run. For each 
concentration tested, five animals were used. Hence, all 
parameters were tested on mitochondrial isolates from five 
separate animals.  In all, 25 animals were used for the five 
different concentrations while the confounding factors of 
using different animals for different extracts were statistically 
accounted for. Results were analyzed using student's t test 
and one-way ANOVA followed by Dunnettʼs post-hoc test for 
comparison between control and test groups. All data were 
expressed as mean ± standard error of the mean. ʻpʼ values 
< 0.05 were considered significant. GraphPad Prism 5 and 
Microsoft Excel 2003 were used for the analyses. 
RESULTS  
Figure l shows that there were no significant changes in the 
volumes of intact mitochondria respiring on succinate in the 
absence of calcium, while the ion induced the opening of 
mitochondrial membrane permeability transition pore up to 
about 14.7−fold in the presence of substrate (CaCl2) and 
rotenone. In Figure 2, spermine, a standard inhibitor of 
calcium-induced mitochondrial membrane permeability 
transition pore opening prevented the opening of the pore by 
about 83%.  Figure 3 shows the in vitro induction of rat liver 
MMPTP opening by varying concentrations (0.2, 0.4, 0.6, 0.8 
and 1.0 mg/ml) of the ME of M. charantia leaves. The ME 
induced MMPTP opening in a concentration−dependent 
manner, albeit,  induction decreased with increasing 
concentrations of  extract.  Increases  in  MMPTPʻs  extents  
of  opening  varied  between  4.3−fold  and  5.5−fold  when 
compared with untreated mitochondria (without triggering 
agent). Maximal induction (5.5−fold) was seen at the least 
concentration (0.2 mg/ml) and the least induction (4.3−fold) 
seen at the highest concentration of ME (1.0 mg/ml). The 
induction seen at 0.4 mg/ml, 0.6 mg/ml and 0.8 mg/ml were 
4.8−fold, 4.8−fold and 4.4−fold respectively. Accordingly, 
swelling was significantly reversed in the presence of 4mM 





Figure 2: In vitro induction of rat liver MMPTP opening by 
varying concentrations of methanol extract (ME) of M. 
Charantia. A: No Triggering (Control); B: Triggering Agent (300 µM 
CaCl2); C: Spermine inhibition (300 µM CaCl2 + 4 mM Spermine); D: 
0.2 mg/ml ME; E: 0.2 mg/ml ME +  4 mM Spermine; F: 0.4 mg/ml 
ME; G: 0.4 mg/ml ME +  4 mM Spermine; H: 0.6 mg/ml ME; I: 0.6 
mg/ml ME +  4 mM Spermine; J: 0.8 mg/ml ME; K: 0.8 mg/ml ME +  
4 mM Spermine; L: 1.0 mg/ml ME; M: 1.0 mg/ml ME +  4 mM 
Spermine. Conditions were same as in Figure 1, except that varying 
concentrations (0.2, 0.4, 0.6, 0.8 and 1.0 mg/ml) of methanol extract 
(ME) were immediately introduced after the addition of rotenone in 
place of spermine, the reference inhibitor and just before the addition 
of mitochondria for the determination of the effects of the methanol 
extracts on MMPTP opening. In experiments on spermine inhibiton 
of extract-induced MMPTP opening, samples were treated with both 
spermine and the appropriate concentration of DE. Traces D, F, H, 
J, and L represent the extent of swelling caused by the varying 
concentrations of ME  (changes in absorbance becomes more 
negative with decreasing concentrations). The proportional reversal 
to more positive light absorbance in the presence of spermine 
(Traces E, G, I, K, and M) establishes the involvement of MMPTP 
opening in the observed mitochondrial swelling. The results shown 
are representative of five such experiments. The data set in A, B, 
and C are same as shown in Figure 1. 




Figure 3: In vitro induction of rat liver MMPTP opening by 
varying concentrations of  leaf decoction (DE) of M. Charantia. 
A: No Triggering (Control); B: Triggering Agent (300 µM CaCl2); C: 
Spermine inhibition (300 µM CaCl2 + 4 mM Spermine); D: 0.2 mg/ml 
DE; E: 0.2 mg/ml DE +  4 mM Spermine; F: 0.4 mg/ml DE; G: 0.4 
mg/ml DE +  4 mM Spermine; H: 0.6 mg/ml DE; I: 0.6 mg/ml DE +  4 
mM Spermine; J: 0.8 mg/ml DE; K: 0.8 mg/ml DE +  4 mM 
Spermine; L: 1.0 mg/ml DE; M: 1.0 mg/ml DE +  4 mM Spermine. 
Conditions were same as in Figure 1, except that varying 
concentrations (0.2, 0.4, 0.6, 0.8 and 1.0 mg/ml) of methanol extract 
(DE) were immediately introduced after the addition of rotenone in 
place of spermine, the reference inhibitor and just before the addition 
of mitochondria for the determination of the effects of the methanol 
extracts on MMPTP opening. In experiments on spermine inhibiton 
of extract-induced MMPTP opening, samples were treated with both 
spermine and the appropriate concentration of DE.  Traces D, F, H, 
J, and L represent the extent of swelling caused by the varying 
concentrations of DE (changes in absorbance becomes more 
negative with increasing concentrations). The proportional reversal 
to more positive light absorbance in the presence of spermine 
(Traces E, G, I, K, and M) establishes the involvement of MMPTP 
opening in the observed mitochondrial swelling. The results shown 
are representative of five such experiments. The data set in A, B, 
and C are same as shown in Figure 1. 
 
Figure 4 shows the in vitro induction of rat liver MMPTP 
opening by varying concentrations of leaf decoction (DE) of 
M. charantia. Varying concentrations of DE induced MMPTP 
opening in a concentration-dependent manner, with the 
induction increasing with increasing concentrations of 
extract. Fold increases in MMPTPʼs extents of opening were 
seen between 4.3 and 7.1 folds. The maximal induction of 
7.1−fold was seen at the highest concentration (1.0 mg/ml) 
and the least induction (4.3−fold) seen at the least 
concentration of DE (0.2 mg/ml). The inductions seen at 0.4 
mg/ml, 0.6 mg/ml and 0.8 mg/ml were 4.8−fold, 5.0−fold and 
6.7−fold increases respectively in comparison to the control 
group. All increases in MMPTP opening caused by DE of M. 
charantia leaves were reversed by spermine. In Figure 5, 
the in vitro induction of rat liver MMPTP opening by varying 
concentrations of Crude Water-Soluble Extract (CWSE) of 
M. charantia leaves are shown. Varying concentrations of 
CWSE induced MMPTP in a concentration-dependent 
manner, with the degree of opening of the pore increasing 
with increasing concentrations of extract. Fold increases in 
MMPTP extents of opening were observed to be between 
4.6 and 8.1 fold. Maximal induction (8.1−fold) was seen at 
the highest concentration (1.0 mg/ml) and the least induction 
(4.6-fold) seen at the least concentration of CWSE (0.2 
mg/ml). The inductions seen at 0.4 mg/ml, 0.6 mg/ml and 0.8 
mg/ml were 4.8, 5.6 and 6.9−folds respectively in 
comparison to the control group. All increases in MMPTP 
opening caused by CWSE of M. charantia leaves were 
reversed by spermine.  
 
Figure 4: In vitro induction of rat liver MMPTP opening by 
varying concentrations of Crude Water-Soluble Extract (CWSE) 
of M. charantia. A: No Triggering (Control); B: Triggering Agent 
(300 µM CaCl2); C: Spermine inhibition (300 µM CaCl2 + 4 mM 
Spermine); D: 0.2 mg/ml CWSE; E: 0.2 mg/ml CWSE + 4 mM 
Spermine; F: 0.4 mg/ml CWSE; G: 0.4 mg/ml CWSE + 4 mM 
Spermine; H: 0.6 mg/ml CWSE; I: 0.6 mg/ml CWSE +  4 mM 
Spermine; J: 0.8 mg/ml CWSE; K: 0.8 mg/ml CWSE + 4 mM 
Spermine; L: 1.0 mg/ml CWSE; M: 1.0 mg/ml CWSE + 4 mM 
Spermine. Conditions were same as in Figure 1, except that varying 
concentrations (0.2, 0.4, 0.6, 0.8 and 1.0 mg/ml) of Crude Water-
Soluble Extract (CWSE) were immediately introduced after the 
addition of rotenone in place of spermine, the reference inhibitor and 
just before the addition of mitochondria for the determination of the 
effects of the methanol extracts on MMPTP opening. In experiments 
on spermine inhibiton of extract-induced MMPTP opening, samples 
were treated with both spermine and the appropriate concentration 
of DE.  Traces D, F, H, J, and L represent the extent of swelling 
caused by the varying concentrations of CWSE (changes in 
absorbance becomes more negative with increasing concentrations). 
The proportional reversal to more positive light absorbance in the 
presence of spermine (Traces E, G, I, K, and M) establishes the 
involvement of MMPTP opening in the observed mitochondrial 
swelling. The results shown are representative of five such 
experiments. The data set in A, B, and C are same as shown in 
Figure 1. 
 
The effects of the three extract types (ME, DE and CWSE) of 
M. charantia leaves were compared with the control group in 
Figure 6; there were dose-dependent increases in the extent 
of in vitro rat liver MMPTP induction by the tested leaf 
extracts of M. charantia compared with the control group 
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(normal control rats). Table 1 summarizes the effects of the 
three extract types (CWSE, DE and ME) on MPTP opening. 
The highest induction; that caused by  CWSE,  being  as  
much  as  about  55%  of  that  caused  by  Ca2+,  a standard 
inducer/trigger of the pore opening (Bernandi  et al., 1998; 
Halestrap  et al ., 1998).  Our results thus reveal that the 
three extract types are potent inducers of the mitochondrial 
membrane permeability transition pore opening, albeit to 
varying extents.  
 
Figure 5: Comparison of the extents of induction of rat liver 
mitochondrial membrane permeability transition pore opening 
by the extracts of M. charantia. Bar charts shown are means ± 
S.E.M of data from five separate experiments using different 
mitochondrial preparations.  
 
DISCUSSION 
This study shows the potency of the extracts CWSE, DE 
and ME of M. charantia leaves in the induction of MMPTP 
opening. Of the three extracts, the CWSE was the most 
potent as evidenced by its induction of MMPTP opening 
up to about 8.1-fold increase in comparison with the 
control group and the highest inductions seen with the 
other two groups (7.1 and 5.5−folds for DE and ME, 
respectively). Though extents and patterns of increase of 
MMPTP opening were varied, the three extracts clearly 
caused large amplitude swelling of the isolated 
mitochondria (least induction being about 4-fold increase 
compared with control group), an indication of their ability 
to alter the permeability transition of the affected 
mitochondria (Harworth and Hunter, 1979). MMPTP is a 
non-selective, high-conductance channel with multiple 
macromolecular components (Alano et al., 2002), such as 
Adenine Nucleotide Translocase (ANT) and cyclophilin D 
(Javadov et al., 2009), which form at sites where the 
inner and outer membranes of the mitochondrion meet 
(Crompton, 1999). The opening of the mitochondrial 
membrane permeability transition pore which could be 
triggered by Ca2+, Pi (inorganic phosphate), oxidative 
stress, and inhibited by cyclosporin A, bongkrekic acid, 
EGTA, adenine nucleotides, and Mg2+ (Bernandi et al., 
1998; Halestrap et al., 1998) is a critical stage of apoptosis 
because it results in swelling and ultimate rupture of the 
outer membrane as well as the redistribution of 
proapoptotic proteins such as cytochrome c and 
apoptosis inducing factor (AIF) from the mitochondria to 
the cytoplasm (Petit et al., 1996; Susin et al., 1996; 
Skulachev, 1996; Petit et al., 1998). Once released, 
cytochrome c binds to apoptotic protease activator factor-
1 (APAF-1) in the presence of ATP or dATP and forms a 
complex that processes and activates pro−caspase−3 
and pro−caspase−7 (Kroemer, 2002), which ultimately 
commit the cell to self destruction (apoptosis) (Deckwerth 
and Johnson, 1993; Newmeyer et al., 1994). Apoptosis is 
one of the most potent cellular defenses against cancer, 
because it destroys potentially deleterious and mutated cells 
(Reed, 1999).  
 
Table 1: Fold increases in MMPTP opening caused by extracts 
of M.    charantia. 
Values are extract-induced fold increases in MMPTP opening 
relative to control experiments in which no triggering agents were 
included. *Values which significantly (P<0.05) decreased when 
compared with control animals. The changes in absorbance shown 
here (mean ± S.E.M.) are same as the 25 data points (the 25 values 
obtained fom time 0−12 min.) used in Figures 2−4 for the varying 
concentrations of each extract type. They compared the extent of 
mitochondrial swelling (MMPTP opening) seen at these varying 
concentrations. ME (Methanolic Extract), DE (Decoction) and 
CWSE (Crude Water-Soluble Extract).  
 
Two common pathways of apoptosis (the intrinsic or 
mitochondrial-mediated and the extrinsic or death receptor-
mediated pathways) are well-recognized (Alimonti et al., 
2003) and the mitochondrial-mediated pathway is the 
pathway by which many dietary bioactive agents induce 
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apoptosis, having altered mitochondrial membrane function 
and/or dissipated the mitochondrial potential (Galati and 
OʼBrien, 2000; Ueda et al., 2001; Morin et al., 2001; Kim et 
al., 2003; Palozza et al., 2003; Hantz et al., 2005; Martin, 
2006). The anti-cancer efficacies of M. charantia in various 
cancers have also been observed (Grover and Yadav, 2004); 
indeed, several groups of investigators have shown that the 
mechanism by which M. charantia causes cell death in 
certain cancer cell lines is through apoptosis (Kobori et al., 
2008; Ray et al., 2010; Li et al., 2012; Fang et al., 2012). 
However, aside from the reports of Odewusi et al., (2010) on 
the in vivo induction of MMPTP opening by the leaf decoction 
of M. charantia in male albino rats, reports on the role of the 
plant in the induction of MMPTP opening are quite few and 
far between.  
Owing to the critical role played by MMPTP opening in 
apoptotic cell deaths, a well documented means by which M. 
charantia induces cancer cell death (Kobori et al., 2008; Ray 
et al., 2010; Fang et al., 2012; Li et al., 2012) and the fact 
that the MMPTP itself can be considered a potential 
therapeutic target in cancer chemotherapeutics (Brenner and 
Grimm, 2006), our interest in the current study is kindled. 
These results, apart from showing that heating may be a 
factor in the extent of induction caused by the leaf 
extracts, also suggest that the types of solvent used in 
extracting the leaves of the plant equally affect extract 
potency (i.e., order of potency is: CWSE >DE > ME). The 
induction observed at 1mg/ml of CWSE translates to about 
55% of the induction caused by Ca2+, a known trigger of 
MMPTP opening (Bernandi et al., 1998; Halestrap et al., 
1998). This work thus suggests a strong connection 
between the anti-cancer effects of Momordica charantia 
and its ability to induce mitochondrial-mediated (intrinsic) 
apoptosis in cancer cells. The extract of Momordica 
charantia best-suited for the induction of MMPTP opening 
in rat liver is CWSE. 
Conclusion 
We conclude that the pre-incubation of the tested leaf extracts 
[Crude Water-Soluble Extract (CWSE), Decoction (DE) and 
Methanol Extract (ME)] of M. charantia with isolated rat liver 
mitochondria induced large amplitude mitochondrial swelling 
and that M. charantia is likely one of the many bioactive 
agents which cause cancer cell death by the induction of the 
intrinsic (mitochondrial-mediated) pathway of apoptosis. Of 
the three extracts investigated, CWSE is the most potent 
inducer of MMPTP opening. Further work on the isolation and 
identification of the active chemicals in the CWSE responsible 
for the above observation is in progress. 
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